Synedica Glow Pen
Synedica Glow Skin 112mg Pen – Advanced Cosmetic Peptide Blend
Synedica Glow Skin 112mg Pen is a precision-formulated peptide blend developed for cosmetic and regenerative research applications. This advanced investigational formulation combines GHK-CU, BPC-157 and TB-500 within a stabilised delivery system designed for controlled laboratory protocols.
Each pen contains a total peptide content of 112mg, including 80mg GHK-CU, 16mg BPC-157 and 16mg TB-500. The prefilled pen format eliminates the need for reconstitution while supporting convenient and repeatable administration within research environments.
Buy Glow GHK-CU UK
Injection Pen Kit
Triple-peptide formulation combining GHK-Cu, BPC-157, and TB-500 for skin rejuvenation, anti-aging, and tissue recovery research. Stimulates collagen production, accelerates tissue repair, enhances elasticity, reduces inflammation, and strengthens hair follicles for visibly youthful, radiant complexion research applications.
Key Features
- 112mg total peptide blend per pen
- 80mg GHK-CU formulation
- 16mg BPC-157 included
- 16mg TB–500 included
- Prefilled precision dosing pen
- No reconstitution required
- Developed for cosmetic and regenerative investigation
- Manufactured by Synedica
How to Use
- Attach a sterile compatible pen needle before use
- Prime the pen if required according to instructions
- Select the desired amount based on research protocol
- Administer via subcutaneous route where applicable
- Store refrigerated between 2–8°C
How It Works
- GHK-CU is researched for cosmetic and cellular regeneration pathways
- BPC-157 is investigated in repair–focused experimental models
- TB-500 is studied for cellular activity and recovery environments
- The combined formulation supports broader investigational peptide research
Recommended Research Pairings
- May complement broader cosmetic peptide protocols
- Often investigated alongside regenerative research compounds
- Can be included within advanced laboratory peptide studies








Reviews
There are no reviews yet.